Antihemophilic Factor (Recombinant) PEGylated

CHEBI:CHEBI_747658

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

dosage_form
KIT
listing_expiration_date
20251231
marketing_category
BLA
product_type
PLASMA DERIVATIVE
marketing_start_date
20160728
package_marketing_start_date
20160728
generic_name
Antihemophilic Factor (Recombinant) PEGylated
brand_name
ADYNOVATE
brand_name_base
ADYNOVATE
product_ndc
0944-4623
application_number
BLA125566
labeler_name
Takeda Pharmaceuticals Amercia, Inc.
spl_id
215d2368-3d55-4bf5-adce-cc4d43c566f6
package_ndc
0944-4623-01
package_description
1 KIT in 1 CARTON (0944-4623-01) / 1 CONTAINER in 1 KIT (0944-4623-02) / 1 KIT in 1 CONTAINER (0944-4623-03) * 5 mL in 1 VIAL, GLASS (0944-4138-01) * 2 mL in 1 VIAL, GLASS (64764-514-02)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class